nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A5—prostate cancer	0.15	0.473	CbGaD
Delavirdine—CYP2C19—prostate cancer	0.102	0.322	CbGaD
Delavirdine—CYP3A4—prostate cancer	0.065	0.205	CbGaD
Delavirdine—CYP2C8—Nilutamide—prostate cancer	0.0219	0.0497	CbGbCtD
Delavirdine—CYP3A5—Flutamide—prostate cancer	0.0188	0.0428	CbGbCtD
Delavirdine—CYP2C19—Nilutamide—prostate cancer	0.0183	0.0417	CbGbCtD
Delavirdine—CYP2C19—Bicalutamide—prostate cancer	0.0183	0.0417	CbGbCtD
Delavirdine—CYP2C8—Abiraterone—prostate cancer	0.0181	0.0412	CbGbCtD
Delavirdine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0169	0.0384	CbGbCtD
Delavirdine—CYP2C9—Bicalutamide—prostate cancer	0.0153	0.0347	CbGbCtD
Delavirdine—CYP2C9—Nilutamide—prostate cancer	0.0153	0.0347	CbGbCtD
Delavirdine—CYP2C19—Flutamide—prostate cancer	0.0152	0.0346	CbGbCtD
Delavirdine—CYP1A2—Flutamide—prostate cancer	0.014	0.0319	CbGbCtD
Delavirdine—CYP2D6—Bicalutamide—prostate cancer	0.0139	0.0317	CbGbCtD
Delavirdine—CYP3A5—Cabazitaxel—prostate cancer	0.0139	0.0317	CbGbCtD
Delavirdine—CYP3A5—Estrone—prostate cancer	0.0136	0.031	CbGbCtD
Delavirdine—CYP2C8—Cabazitaxel—prostate cancer	0.0134	0.0305	CbGbCtD
Delavirdine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0117	0.0265	CbGbCtD
Delavirdine—CYP2D6—Abiraterone—prostate cancer	0.0116	0.0263	CbGbCtD
Delavirdine—CYP3A7—Estradiol—prostate cancer	0.0104	0.0237	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0104	0.0237	CbGbCtD
Delavirdine—CYP1A2—Estrone—prostate cancer	0.0101	0.023	CbGbCtD
Delavirdine—CYP2C9—Estrone—prostate cancer	0.00914	0.0208	CbGbCtD
Delavirdine—CYP3A4—Bicalutamide—prostate cancer	0.00887	0.0202	CbGbCtD
Delavirdine—CYP3A4—Estramustine—prostate cancer	0.00824	0.0187	CbGbCtD
Delavirdine—CYP3A5—Estradiol—prostate cancer	0.00783	0.0178	CbGbCtD
Delavirdine—CYP2C8—Estradiol—prostate cancer	0.00752	0.0171	CbGbCtD
Delavirdine—CYP3A4—Flutamide—prostate cancer	0.00735	0.0167	CbGbCtD
Delavirdine—CYP3A4—Abiraterone—prostate cancer	0.00735	0.0167	CbGbCtD
Delavirdine—CYP2C9—Capecitabine—prostate cancer	0.00692	0.0157	CbGbCtD
Delavirdine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00663	0.0151	CbGbCtD
Delavirdine—CYP2C19—Estradiol—prostate cancer	0.00631	0.0143	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00623	0.0142	CbGbCtD
Delavirdine—CYP3A7—Docetaxel—prostate cancer	0.00623	0.0142	CbGbCtD
Delavirdine—CYP1A2—Estradiol—prostate cancer	0.00582	0.0132	CbGbCtD
Delavirdine—CYP3A4—Cabazitaxel—prostate cancer	0.00544	0.0124	CbGbCtD
Delavirdine—CYP2C19—Prednisone—prostate cancer	0.00543	0.0123	CbGbCtD
Delavirdine—CYP3A4—Estrone—prostate cancer	0.00531	0.0121	CbGbCtD
Delavirdine—CYP2C9—Estradiol—prostate cancer	0.00525	0.0119	CbGbCtD
Delavirdine—CYP3A5—Etoposide—prostate cancer	0.00511	0.0116	CbGbCtD
Delavirdine—CYP2C8—Etoposide—prostate cancer	0.00491	0.0112	CbGbCtD
Delavirdine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00474	0.0108	CbGbCtD
Delavirdine—CYP3A5—Docetaxel—prostate cancer	0.00467	0.0106	CbGbCtD
Delavirdine—CYP1A2—Etoposide—prostate cancer	0.0038	0.00864	CbGbCtD
Delavirdine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00348	0.0079	CbGbCtD
Delavirdine—CYP3A4—Mitoxantrone—prostate cancer	0.00316	0.00718	CbGbCtD
Delavirdine—CYP3A4—Estradiol—prostate cancer	0.00305	0.00694	CbGbCtD
Delavirdine—CYP3A4—Prednisone—prostate cancer	0.00262	0.00596	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—prostate cancer	0.00214	0.00486	CbGbCtD
Delavirdine—CYP3A4—Etoposide—prostate cancer	0.00199	0.00453	CbGbCtD
Delavirdine—CYP3A4—Docetaxel—prostate cancer	0.00182	0.00414	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—prostate cancer	0.00136	0.00309	CbGbCtD
Delavirdine—CYP2C19—urine—prostate cancer	0.000549	0.193	CbGeAlD
Delavirdine—CYP1A2—urine—prostate cancer	0.000448	0.158	CbGeAlD
Delavirdine—CYP2C9—urine—prostate cancer	0.000426	0.15	CbGeAlD
Delavirdine—CYP3A4—urine—prostate cancer	0.000324	0.114	CbGeAlD
Delavirdine—CYP2D6—urine—prostate cancer	0.000319	0.112	CbGeAlD
Delavirdine—CYP3A5—prostate gland—prostate cancer	0.000155	0.0547	CbGeAlD
Delavirdine—CYP2C8—renal system—prostate cancer	0.000117	0.0413	CbGeAlD
Delavirdine—CYP1A2—renal system—prostate cancer	0.00011	0.0386	CbGeAlD
Delavirdine—CYP3A5—renal system—prostate cancer	0.000106	0.0373	CbGeAlD
Delavirdine—CYP3A4—renal system—prostate cancer	7.94e-05	0.028	CbGeAlD
Delavirdine—CYP2D6—renal system—prostate cancer	7.81e-05	0.0275	CbGeAlD
Delavirdine—CYP2C8—testis—prostate cancer	7.58e-05	0.0267	CbGeAlD
Delavirdine—CYP2D6—testis—prostate cancer	5.05e-05	0.0178	CbGeAlD
Delavirdine—Hypoaesthesia—Epirubicin—prostate cancer	2.6e-05	0.000167	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—prostate cancer	2.6e-05	0.000166	CcSEcCtD
Delavirdine—Skin disorder—Capecitabine—prostate cancer	2.59e-05	0.000166	CcSEcCtD
Delavirdine—Hyperhidrosis—Capecitabine—prostate cancer	2.58e-05	0.000165	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—prostate cancer	2.58e-05	0.000165	CcSEcCtD
Delavirdine—Hypotension—Docetaxel—prostate cancer	2.57e-05	0.000165	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—prostate cancer	2.57e-05	0.000165	CcSEcCtD
Delavirdine—Loss of consciousness—Prednisone—prostate cancer	2.56e-05	0.000164	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—prostate cancer	2.54e-05	0.000163	CcSEcCtD
Delavirdine—Anorexia—Capecitabine—prostate cancer	2.54e-05	0.000163	CcSEcCtD
Delavirdine—Nausea—Estradiol—prostate cancer	2.54e-05	0.000163	CcSEcCtD
Delavirdine—Vomiting—Mitoxantrone—prostate cancer	2.53e-05	0.000163	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—prostate cancer	2.53e-05	0.000162	CcSEcCtD
Delavirdine—Hypertension—Prednisone—prostate cancer	2.51e-05	0.000161	CcSEcCtD
Delavirdine—Rash—Mitoxantrone—prostate cancer	2.51e-05	0.000161	CcSEcCtD
Delavirdine—Dermatitis—Mitoxantrone—prostate cancer	2.51e-05	0.000161	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.51e-05	0.000161	CcSEcCtD
Delavirdine—Headache—Mitoxantrone—prostate cancer	2.5e-05	0.00016	CcSEcCtD
Delavirdine—Hypotension—Capecitabine—prostate cancer	2.49e-05	0.00016	CcSEcCtD
Delavirdine—Insomnia—Docetaxel—prostate cancer	2.49e-05	0.00016	CcSEcCtD
Delavirdine—Arthralgia—Prednisone—prostate cancer	2.48e-05	0.000159	CcSEcCtD
Delavirdine—Myalgia—Prednisone—prostate cancer	2.48e-05	0.000159	CcSEcCtD
Delavirdine—Paraesthesia—Docetaxel—prostate cancer	2.47e-05	0.000159	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—prostate cancer	2.47e-05	0.000159	CcSEcCtD
Delavirdine—Anxiety—Prednisone—prostate cancer	2.47e-05	0.000158	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—prostate cancer	2.46e-05	0.000158	CcSEcCtD
Delavirdine—Dyspnoea—Docetaxel—prostate cancer	2.46e-05	0.000158	CcSEcCtD
Delavirdine—Somnolence—Docetaxel—prostate cancer	2.45e-05	0.000157	CcSEcCtD
Delavirdine—Discomfort—Prednisone—prostate cancer	2.45e-05	0.000157	CcSEcCtD
Delavirdine—Hypersensitivity—Etoposide—prostate cancer	2.44e-05	0.000157	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—prostate cancer	2.44e-05	0.000156	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.43e-05	0.000156	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—prostate cancer	2.43e-05	0.000156	CcSEcCtD
Delavirdine—Dyspepsia—Docetaxel—prostate cancer	2.42e-05	0.000156	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—prostate cancer	2.42e-05	0.000155	CcSEcCtD
Delavirdine—Insomnia—Capecitabine—prostate cancer	2.41e-05	0.000155	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—prostate cancer	2.41e-05	0.000154	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—prostate cancer	2.4e-05	0.000154	CcSEcCtD
Delavirdine—Paraesthesia—Capecitabine—prostate cancer	2.39e-05	0.000154	CcSEcCtD
Delavirdine—Decreased appetite—Docetaxel—prostate cancer	2.39e-05	0.000154	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—prostate cancer	2.38e-05	0.000153	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.38e-05	0.000153	CcSEcCtD
Delavirdine—Asthenia—Etoposide—prostate cancer	2.38e-05	0.000153	CcSEcCtD
Delavirdine—Dyspnoea—Capecitabine—prostate cancer	2.38e-05	0.000153	CcSEcCtD
Delavirdine—Oedema—Prednisone—prostate cancer	2.38e-05	0.000152	CcSEcCtD
Delavirdine—Fatigue—Docetaxel—prostate cancer	2.37e-05	0.000152	CcSEcCtD
Delavirdine—Nausea—Mitoxantrone—prostate cancer	2.37e-05	0.000152	CcSEcCtD
Delavirdine—Infection—Prednisone—prostate cancer	2.36e-05	0.000151	CcSEcCtD
Delavirdine—Pain—Docetaxel—prostate cancer	2.36e-05	0.000151	CcSEcCtD
Delavirdine—Constipation—Docetaxel—prostate cancer	2.36e-05	0.000151	CcSEcCtD
Delavirdine—Dyspepsia—Capecitabine—prostate cancer	2.35e-05	0.000151	CcSEcCtD
Delavirdine—Chills—Epirubicin—prostate cancer	2.35e-05	0.000151	CcSEcCtD
Delavirdine—Pruritus—Etoposide—prostate cancer	2.35e-05	0.00015	CcSEcCtD
Delavirdine—Shock—Prednisone—prostate cancer	2.34e-05	0.00015	CcSEcCtD
Delavirdine—Tachycardia—Prednisone—prostate cancer	2.32e-05	0.000149	CcSEcCtD
Delavirdine—Decreased appetite—Capecitabine—prostate cancer	2.32e-05	0.000149	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—prostate cancer	2.31e-05	0.000148	CcSEcCtD
Delavirdine—Skin disorder—Prednisone—prostate cancer	2.31e-05	0.000148	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.3e-05	0.000148	CcSEcCtD
Delavirdine—Fatigue—Capecitabine—prostate cancer	2.3e-05	0.000147	CcSEcCtD
Delavirdine—Hyperhidrosis—Prednisone—prostate cancer	2.3e-05	0.000147	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—prostate cancer	2.29e-05	0.000147	CcSEcCtD
Delavirdine—Pain—Capecitabine—prostate cancer	2.28e-05	0.000146	CcSEcCtD
Delavirdine—Constipation—Capecitabine—prostate cancer	2.28e-05	0.000146	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—prostate cancer	2.28e-05	0.000146	CcSEcCtD
Delavirdine—Erythema—Epirubicin—prostate cancer	2.28e-05	0.000146	CcSEcCtD
Delavirdine—Feeling abnormal—Docetaxel—prostate cancer	2.27e-05	0.000146	CcSEcCtD
Delavirdine—Diarrhoea—Etoposide—prostate cancer	2.27e-05	0.000145	CcSEcCtD
Delavirdine—Anorexia—Prednisone—prostate cancer	2.26e-05	0.000145	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—prostate cancer	2.26e-05	0.000145	CcSEcCtD
Delavirdine—Gastrointestinal pain—Docetaxel—prostate cancer	2.25e-05	0.000144	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—prostate cancer	2.24e-05	0.000144	CcSEcCtD
Delavirdine—Tension—Epirubicin—prostate cancer	2.23e-05	0.000143	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—prostate cancer	2.23e-05	0.000143	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—prostate cancer	2.21e-05	0.000142	CcSEcCtD
Delavirdine—Back pain—Epirubicin—prostate cancer	2.2e-05	0.000141	CcSEcCtD
Delavirdine—Feeling abnormal—Capecitabine—prostate cancer	2.2e-05	0.000141	CcSEcCtD
Delavirdine—Dizziness—Etoposide—prostate cancer	2.19e-05	0.000141	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—prostate cancer	2.19e-05	0.00014	CcSEcCtD
Delavirdine—Gastrointestinal pain—Capecitabine—prostate cancer	2.18e-05	0.00014	CcSEcCtD
Delavirdine—Abdominal pain—Docetaxel—prostate cancer	2.18e-05	0.00014	CcSEcCtD
Delavirdine—Body temperature increased—Docetaxel—prostate cancer	2.18e-05	0.00014	CcSEcCtD
Delavirdine—Chills—Doxorubicin—prostate cancer	2.17e-05	0.000139	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.16e-05	0.000139	CcSEcCtD
Delavirdine—Insomnia—Prednisone—prostate cancer	2.15e-05	0.000138	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—prostate cancer	2.15e-05	0.000138	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—prostate cancer	2.14e-05	0.000137	CcSEcCtD
Delavirdine—Paraesthesia—Prednisone—prostate cancer	2.13e-05	0.000137	CcSEcCtD
Delavirdine—Urticaria—Capecitabine—prostate cancer	2.12e-05	0.000136	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Body temperature increased—Capecitabine—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Abdominal pain—Capecitabine—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Vomiting—Etoposide—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—prostate cancer	2.11e-05	0.000135	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—prostate cancer	2.1e-05	0.000135	CcSEcCtD
Delavirdine—Agitation—Epirubicin—prostate cancer	2.09e-05	0.000134	CcSEcCtD
Delavirdine—Dyspepsia—Prednisone—prostate cancer	2.09e-05	0.000134	CcSEcCtD
Delavirdine—Rash—Etoposide—prostate cancer	2.09e-05	0.000134	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—prostate cancer	2.09e-05	0.000134	CcSEcCtD
Delavirdine—Headache—Etoposide—prostate cancer	2.08e-05	0.000133	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—prostate cancer	2.08e-05	0.000133	CcSEcCtD
Delavirdine—Tension—Doxorubicin—prostate cancer	2.07e-05	0.000133	CcSEcCtD
Delavirdine—Decreased appetite—Prednisone—prostate cancer	2.07e-05	0.000132	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—prostate cancer	2.06e-05	0.000132	CcSEcCtD
Delavirdine—Malaise—Epirubicin—prostate cancer	2.05e-05	0.000132	CcSEcCtD
Delavirdine—Fatigue—Prednisone—prostate cancer	2.05e-05	0.000131	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—prostate cancer	2.05e-05	0.000131	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—prostate cancer	2.05e-05	0.000131	CcSEcCtD
Delavirdine—Syncope—Epirubicin—prostate cancer	2.04e-05	0.000131	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—prostate cancer	2.04e-05	0.000131	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—prostate cancer	2.04e-05	0.000131	CcSEcCtD
Delavirdine—Constipation—Prednisone—prostate cancer	2.03e-05	0.00013	CcSEcCtD
Delavirdine—Hypersensitivity—Docetaxel—prostate cancer	2.03e-05	0.00013	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—prostate cancer	2.03e-05	0.00013	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—prostate cancer	2.01e-05	0.000129	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—prostate cancer	2e-05	0.000128	CcSEcCtD
Delavirdine—Cough—Epirubicin—prostate cancer	1.99e-05	0.000127	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—prostate cancer	1.99e-05	0.000127	CcSEcCtD
Delavirdine—Asthenia—Docetaxel—prostate cancer	1.98e-05	0.000127	CcSEcCtD
Delavirdine—Nausea—Etoposide—prostate cancer	1.97e-05	0.000126	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—prostate cancer	1.97e-05	0.000126	CcSEcCtD
Delavirdine—Hypersensitivity—Capecitabine—prostate cancer	1.96e-05	0.000126	CcSEcCtD
Delavirdine—Feeling abnormal—Prednisone—prostate cancer	1.96e-05	0.000126	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—prostate cancer	1.95e-05	0.000125	CcSEcCtD
Delavirdine—Pruritus—Docetaxel—prostate cancer	1.95e-05	0.000125	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—prostate cancer	1.95e-05	0.000125	CcSEcCtD
Delavirdine—Gastrointestinal pain—Prednisone—prostate cancer	1.94e-05	0.000125	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—prostate cancer	1.94e-05	0.000124	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—prostate cancer	1.94e-05	0.000124	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—prostate cancer	1.94e-05	0.000124	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—prostate cancer	1.94e-05	0.000124	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—prostate cancer	1.93e-05	0.000124	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—prostate cancer	1.91e-05	0.000123	CcSEcCtD
Delavirdine—Asthenia—Capecitabine—prostate cancer	1.91e-05	0.000123	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—prostate cancer	1.9e-05	0.000122	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—prostate cancer	1.9e-05	0.000122	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—prostate cancer	1.89e-05	0.000121	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—prostate cancer	1.89e-05	0.000121	CcSEcCtD
Delavirdine—Urticaria—Prednisone—prostate cancer	1.89e-05	0.000121	CcSEcCtD
Delavirdine—Pruritus—Capecitabine—prostate cancer	1.89e-05	0.000121	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—prostate cancer	1.89e-05	0.000121	CcSEcCtD
Delavirdine—Diarrhoea—Docetaxel—prostate cancer	1.88e-05	0.000121	CcSEcCtD
Delavirdine—Abdominal pain—Prednisone—prostate cancer	1.88e-05	0.00012	CcSEcCtD
Delavirdine—Body temperature increased—Prednisone—prostate cancer	1.88e-05	0.00012	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—prostate cancer	1.87e-05	0.00012	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—prostate cancer	1.86e-05	0.000119	CcSEcCtD
Delavirdine—Oedema—Epirubicin—prostate cancer	1.86e-05	0.000119	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—prostate cancer	1.85e-05	0.000119	CcSEcCtD
Delavirdine—Infection—Epirubicin—prostate cancer	1.85e-05	0.000118	CcSEcCtD
Delavirdine—Cough—Doxorubicin—prostate cancer	1.84e-05	0.000118	CcSEcCtD
Delavirdine—Shock—Epirubicin—prostate cancer	1.83e-05	0.000117	CcSEcCtD
Delavirdine—Diarrhoea—Capecitabine—prostate cancer	1.82e-05	0.000117	CcSEcCtD
Delavirdine—Dizziness—Docetaxel—prostate cancer	1.82e-05	0.000117	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—prostate cancer	1.82e-05	0.000117	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—prostate cancer	1.82e-05	0.000117	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—prostate cancer	1.81e-05	0.000116	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—prostate cancer	1.8e-05	0.000116	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—prostate cancer	1.8e-05	0.000115	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—prostate cancer	1.79e-05	0.000115	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—prostate cancer	1.79e-05	0.000115	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—prostate cancer	1.79e-05	0.000115	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—prostate cancer	1.79e-05	0.000115	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—prostate cancer	1.77e-05	0.000114	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—prostate cancer	1.77e-05	0.000114	CcSEcCtD
Delavirdine—Dizziness—Capecitabine—prostate cancer	1.76e-05	0.000113	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—prostate cancer	1.75e-05	0.000112	CcSEcCtD
Delavirdine—Vomiting—Docetaxel—prostate cancer	1.75e-05	0.000112	CcSEcCtD
Delavirdine—Hypersensitivity—Prednisone—prostate cancer	1.75e-05	0.000112	CcSEcCtD
Delavirdine—Rash—Docetaxel—prostate cancer	1.74e-05	0.000111	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—prostate cancer	1.74e-05	0.000111	CcSEcCtD
Delavirdine—Dermatitis—Docetaxel—prostate cancer	1.74e-05	0.000111	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—prostate cancer	1.73e-05	0.000111	CcSEcCtD
Delavirdine—Headache—Docetaxel—prostate cancer	1.73e-05	0.000111	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—prostate cancer	1.72e-05	0.00011	CcSEcCtD
Delavirdine—Infection—Doxorubicin—prostate cancer	1.71e-05	0.00011	CcSEcCtD
Delavirdine—Asthenia—Prednisone—prostate cancer	1.7e-05	0.000109	CcSEcCtD
Delavirdine—Vomiting—Capecitabine—prostate cancer	1.7e-05	0.000109	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.69e-05	0.000109	CcSEcCtD
Delavirdine—Shock—Doxorubicin—prostate cancer	1.69e-05	0.000108	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Rash—Capecitabine—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Pruritus—Prednisone—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Dermatitis—Capecitabine—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—prostate cancer	1.68e-05	0.000108	CcSEcCtD
Delavirdine—Headache—Capecitabine—prostate cancer	1.67e-05	0.000107	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—prostate cancer	1.67e-05	0.000107	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—prostate cancer	1.67e-05	0.000107	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—prostate cancer	1.66e-05	0.000107	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—prostate cancer	1.66e-05	0.000106	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—prostate cancer	1.65e-05	0.000106	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—prostate cancer	1.64e-05	0.000105	CcSEcCtD
Delavirdine—Nausea—Docetaxel—prostate cancer	1.64e-05	0.000105	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—prostate cancer	1.64e-05	0.000105	CcSEcCtD
Delavirdine—Diarrhoea—Prednisone—prostate cancer	1.63e-05	0.000104	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—prostate cancer	1.62e-05	0.000104	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—prostate cancer	1.61e-05	0.000103	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.6e-05	0.000103	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—prostate cancer	1.6e-05	0.000103	CcSEcCtD
Delavirdine—Pain—Epirubicin—prostate cancer	1.59e-05	0.000102	CcSEcCtD
Delavirdine—Constipation—Epirubicin—prostate cancer	1.59e-05	0.000102	CcSEcCtD
Delavirdine—Nausea—Capecitabine—prostate cancer	1.58e-05	0.000102	CcSEcCtD
Delavirdine—Dizziness—Prednisone—prostate cancer	1.57e-05	0.000101	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.57e-05	0.0001	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—prostate cancer	1.55e-05	9.97e-05	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—prostate cancer	1.54e-05	9.9e-05	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—prostate cancer	1.53e-05	9.83e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—prostate cancer	1.53e-05	9.82e-05	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—prostate cancer	1.53e-05	9.8e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—prostate cancer	1.52e-05	9.74e-05	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—prostate cancer	1.51e-05	9.71e-05	CcSEcCtD
Delavirdine—Vomiting—Prednisone—prostate cancer	1.51e-05	9.69e-05	CcSEcCtD
Delavirdine—Rash—Prednisone—prostate cancer	1.5e-05	9.61e-05	CcSEcCtD
Delavirdine—Dermatitis—Prednisone—prostate cancer	1.5e-05	9.6e-05	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—prostate cancer	1.49e-05	9.59e-05	CcSEcCtD
Delavirdine—Headache—Prednisone—prostate cancer	1.49e-05	9.55e-05	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.48e-05	9.52e-05	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—prostate cancer	1.48e-05	9.51e-05	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—prostate cancer	1.48e-05	9.47e-05	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—prostate cancer	1.47e-05	9.43e-05	CcSEcCtD
Delavirdine—Pain—Doxorubicin—prostate cancer	1.47e-05	9.43e-05	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—prostate cancer	1.47e-05	9.42e-05	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—prostate cancer	1.47e-05	9.42e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—prostate cancer	1.42e-05	9.09e-05	CcSEcCtD
Delavirdine—Nausea—Prednisone—prostate cancer	1.41e-05	9.05e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.41e-05	9.02e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—prostate cancer	1.37e-05	8.78e-05	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—prostate cancer	1.37e-05	8.76e-05	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—prostate cancer	1.36e-05	8.72e-05	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—prostate cancer	1.36e-05	8.72e-05	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—prostate cancer	1.33e-05	8.55e-05	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—prostate cancer	1.31e-05	8.43e-05	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—prostate cancer	1.27e-05	8.15e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—prostate cancer	1.27e-05	8.12e-05	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—prostate cancer	1.23e-05	7.91e-05	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—prostate cancer	1.23e-05	7.88e-05	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—prostate cancer	1.22e-05	7.8e-05	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—prostate cancer	1.18e-05	7.58e-05	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—prostate cancer	1.18e-05	7.54e-05	CcSEcCtD
Delavirdine—Rash—Epirubicin—prostate cancer	1.17e-05	7.51e-05	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—prostate cancer	1.17e-05	7.51e-05	CcSEcCtD
Delavirdine—Headache—Epirubicin—prostate cancer	1.16e-05	7.47e-05	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—prostate cancer	1.14e-05	7.29e-05	CcSEcCtD
Delavirdine—Nausea—Epirubicin—prostate cancer	1.1e-05	7.08e-05	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—prostate cancer	1.09e-05	7.01e-05	CcSEcCtD
Delavirdine—Rash—Doxorubicin—prostate cancer	1.08e-05	6.95e-05	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—prostate cancer	1.08e-05	6.95e-05	CcSEcCtD
Delavirdine—Headache—Doxorubicin—prostate cancer	1.08e-05	6.91e-05	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—prostate cancer	1.02e-05	6.55e-05	CcSEcCtD
Delavirdine—CYP3A7—Metabolism—INS—prostate cancer	2.83e-06	3.36e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.81e-06	3.35e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.78e-06	3.31e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CREBBP—prostate cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.76e-06	3.28e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—COMT—prostate cancer	2.75e-06	3.28e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.75e-06	3.27e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ACHE—prostate cancer	2.75e-06	3.27e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTP1—prostate cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NAT2—prostate cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ERCC2—prostate cancer	2.73e-06	3.25e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.73e-06	3.25e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GGT1—prostate cancer	2.72e-06	3.24e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.72e-06	3.23e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.71e-06	3.22e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.7e-06	3.22e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NQO1—prostate cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ITPR1—prostate cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.68e-06	3.19e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NQO1—prostate cancer	2.67e-06	3.18e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TH—prostate cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.65e-06	3.15e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.64e-06	3.15e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.64e-06	3.15e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TH—prostate cancer	2.64e-06	3.14e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.63e-06	3.13e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.63e-06	3.13e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.63e-06	3.12e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—LRP2—prostate cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.61e-06	3.1e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.6e-06	3.1e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.59e-06	3.09e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.59e-06	3.08e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—P4HB—prostate cancer	2.57e-06	3.06e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—MTHFR—prostate cancer	2.57e-06	3.06e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.57e-06	3.05e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.56e-06	3.05e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—RXRA—prostate cancer	2.55e-06	3.04e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TYMS—prostate cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PPARA—prostate cancer	2.52e-06	3e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTM1—prostate cancer	2.52e-06	3e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GGT1—prostate cancer	2.5e-06	2.98e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.5e-06	2.98e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GGT1—prostate cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NOS3—prostate cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—LPL—prostate cancer	2.47e-06	2.94e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.47e-06	2.94e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—COMT—prostate cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.45e-06	2.91e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.45e-06	2.91e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.44e-06	2.9e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.43e-06	2.89e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.41e-06	2.87e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.41e-06	2.86e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—MED12—prostate cancer	2.4e-06	2.86e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.39e-06	2.84e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GNG5—prostate cancer	2.38e-06	2.83e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CAV1—prostate cancer	2.37e-06	2.82e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ERCC2—prostate cancer	2.37e-06	2.82e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.37e-06	2.82e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.37e-06	2.82e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—RXRA—prostate cancer	2.35e-06	2.79e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—RXRA—prostate cancer	2.33e-06	2.77e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.31e-06	2.75e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.29e-06	2.73e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.29e-06	2.72e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NQO1—prostate cancer	2.29e-06	2.72e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TYMS—prostate cancer	2.27e-06	2.71e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTGS2—prostate cancer	2.27e-06	2.7e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.26e-06	2.69e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—COMT—prostate cancer	2.26e-06	2.69e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TH—prostate cancer	2.25e-06	2.68e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.25e-06	2.68e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.25e-06	2.67e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—COMT—prostate cancer	2.24e-06	2.67e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.24e-06	2.66e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—MTHFR—prostate cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.22e-06	2.64e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.21e-06	2.63e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—LPL—prostate cancer	2.21e-06	2.63e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.19e-06	2.61e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.19e-06	2.61e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.19e-06	2.6e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PPARA—prostate cancer	2.18e-06	2.6e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.17e-06	2.59e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.16e-06	2.57e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.16e-06	2.57e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.12e-06	2.53e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ACHE—prostate cancer	2.12e-06	2.53e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GGT1—prostate cancer	2.12e-06	2.52e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.1e-06	2.5e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TYMS—prostate cancer	2.09e-06	2.49e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.09e-06	2.49e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TYMS—prostate cancer	2.07e-06	2.47e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.07e-06	2.46e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CAV1—prostate cancer	2.05e-06	2.44e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.05e-06	2.44e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—INS—prostate cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.03e-06	2.42e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—LPL—prostate cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—LPL—prostate cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CREBBP—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—RXRA—prostate cancer	1.99e-06	2.37e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTEN—prostate cancer	1.98e-06	2.35e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.96e-06	2.33e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.96e-06	2.33e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PPARA—prostate cancer	1.95e-06	2.32e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.94e-06	2.31e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.94e-06	2.31e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.93e-06	2.3e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—COMT—prostate cancer	1.92e-06	2.28e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.91e-06	2.28e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.9e-06	2.26e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—EP300—prostate cancer	1.89e-06	2.24e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.88e-06	2.23e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.87e-06	2.22e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.84e-06	2.19e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CAV1—prostate cancer	1.83e-06	2.18e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.81e-06	2.16e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PPARA—prostate cancer	1.79e-06	2.13e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NOS3—prostate cancer	1.79e-06	2.13e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.78e-06	2.12e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PPARA—prostate cancer	1.78e-06	2.11e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TYMS—prostate cancer	1.77e-06	2.11e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—INS—prostate cancer	1.77e-06	2.11e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NQO1—prostate cancer	1.76e-06	2.1e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TH—prostate cancer	1.74e-06	2.07e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—LPL—prostate cancer	1.72e-06	2.05e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CAV1—prostate cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CAV1—prostate cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.66e-06	1.98e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.65e-06	1.97e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.65e-06	1.96e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.64e-06	1.96e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.64e-06	1.95e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GGT1—prostate cancer	1.64e-06	1.95e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.59e-06	1.89e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—INS—prostate cancer	1.58e-06	1.88e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NOS3—prostate cancer	1.55e-06	1.85e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.54e-06	1.83e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—RXRA—prostate cancer	1.53e-06	1.83e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PPARA—prostate cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—COMT—prostate cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.47e-06	1.75e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.47e-06	1.75e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—INS—prostate cancer	1.45e-06	1.73e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.45e-06	1.72e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—INS—prostate cancer	1.44e-06	1.71e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTEN—prostate cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CAV1—prostate cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.41e-06	1.68e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.4e-06	1.66e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NOS3—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TYMS—prostate cancer	1.37e-06	1.63e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—EP300—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.35e-06	1.61e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.61e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.34e-06	1.59e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—LPL—prostate cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.3e-06	1.55e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.28e-06	1.52e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.28e-06	1.52e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NOS3—prostate cancer	1.27e-06	1.52e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NOS3—prostate cancer	1.26e-06	1.5e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTEN—prostate cancer	1.24e-06	1.47e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—INS—prostate cancer	1.23e-06	1.46e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.21e-06	1.43e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.19e-06	1.42e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—EP300—prostate cancer	1.18e-06	1.4e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.18e-06	1.4e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PPARA—prostate cancer	1.17e-06	1.39e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.39e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.17e-06	1.39e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.16e-06	1.37e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—AKT1—prostate cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTEN—prostate cancer	1.11e-06	1.31e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CAV1—prostate cancer	1.1e-06	1.31e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NOS3—prostate cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—EP300—prostate cancer	1.05e-06	1.25e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTEN—prostate cancer	1.02e-06	1.21e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.01e-06	1.2e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTEN—prostate cancer	1.01e-06	1.2e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1e-06	1.19e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.97e-07	1.19e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTGS2—prostate cancer	9.87e-07	1.17e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—EP300—prostate cancer	9.69e-07	1.15e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—EP300—prostate cancer	9.61e-07	1.14e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—INS—prostate cancer	9.5e-07	1.13e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CREBBP—prostate cancer	9.31e-07	1.11e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.82e-07	1.05e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.74e-07	1.04e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTEN—prostate cancer	8.61e-07	1.02e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NOS3—prostate cancer	8.33e-07	9.91e-06	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—AKT1—prostate cancer	8.24e-07	9.8e-06	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—EP300—prostate cancer	8.21e-07	9.77e-06	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.8e-07	9.28e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.69e-07	9.15e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTGS2—prostate cancer	7.62e-07	9.07e-06	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.17e-07	8.53e-06	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—AKT1—prostate cancer	7.14e-07	8.49e-06	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.11e-07	8.46e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTEN—prostate cancer	6.65e-07	7.91e-06	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—AKT1—prostate cancer	6.37e-07	7.58e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—EP300—prostate cancer	6.34e-07	7.54e-06	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.08e-07	7.23e-06	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—AKT1—prostate cancer	5.86e-07	6.97e-06	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—AKT1—prostate cancer	5.81e-07	6.91e-06	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—AKT1—prostate cancer	4.96e-07	5.9e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.69e-07	5.58e-06	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—AKT1—prostate cancer	3.83e-07	4.56e-06	CbGpPWpGaD
